Filed: 2/9/2026ACC: 0001193125-26-042263
📋 What this filing means
BLUE OWL CAPITAL HOLDINGS LP filed this quarterly 13F‑HR report disclosing 81 equity positions with a total reported market value of $1.34B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
81
Positions
$1.34B
Total AUM (reported)
70.01M
Total Shares
Allocation by class
COM$1.25B93.4%
COM SHS$28.60M2.1%
SHS$8.65M0.6%
CDA COM NEW$8.47M0.6%
COM NEW$8.00M0.6%
COM SER A$7.36M0.6%
CL C$6.78M0.5%
Portfolio Concentration
Top 3$1.07B80.2%
4–10$132.37M9.9%
11–25$91.41M6.8%
Rest$41.31M3.1%
Top 3 weight
80.2%
Top 10 weight
90.1%
Voting Authority Distribution
Total shares with voting rights: 0.00
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other81
Dominant voting typeNone · 0.0% of voting shares
Institutional Holdings81
Rows:
BLACKROCK INC COM
DFNDShares945.95K
TypeSH
Market value$1.01B
75.76%
Sole
0.00
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares3.36M
TypeSH
Market value$30.35M
2.27%
Sole
0.00
Shared
0.00
None
0.00
NUVEEN CHURCHILL DIRECT LEND
DFNDShares2.14M
TypeSH
Market value$28.60M
2.14%
Sole
0.00
Shared
0.00
None
0.00
BLUE OWL CAPITAL CORPORATION
DFNDShares2.05M
TypeSH
Market value$26.12M
1.95%
Sole
0.00
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares6.82M
TypeSH
Market value$26.00M
1.95%
Sole
0.00
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
DFNDShares2.35M
TypeSH
Market value$24.33M
1.82%
Sole
0.00
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
DFNDShares3.47M
TypeSH
Market value$18.62M
1.39%
Sole
0.00
Shared
0.00
None
0.00
HOLLEY INC
DFNDShares4.15M
TypeSH
Market value$17.13M
1.28%
Sole
0.00
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
DFNDShares7.43M
TypeSH
Market value$10.93M
0.82%
Sole
0.00
Shared
0.00
None
0.00
CONDUENT INC
DFNDShares4.82M
TypeSH
Market value$9.26M
0.69%
Sole
0.00
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
DFNDShares3.44M
TypeSH
Market value$8.95M
0.67%
Sole
0.00
Shared
0.00
None
0.00
CIVEO CORP
DFNDShares370.53K
TypeSH
Market value$8.47M
0.63%
Sole
0.00
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares1.24M
TypeSH
Market value$7.36M
0.55%
Sole
0.00
Shared
0.00
None
0.00
EYEPOINT INC
DFNDShares392.59K
TypeSH
Market value$7.17M
0.54%
Sole
0.00
Shared
0.00
None
0.00
PROCORE TECHNOLOGIES INC
DFNDShares94.26K
TypeSH
Market value$6.86M
0.51%
Sole
0.00
Shared
0.00
None
0.00
DELL TECHNOLOGIES INC
DFNDShares53.85K
TypeSH
Market value$6.78M
0.51%
Sole
0.00
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
DFNDShares360K
TypeSH
Market value$5.81M
0.44%
Sole
0.00
Shared
0.00
None
0.00
MAPLIGHT THERAPEUTICS INC
DFNDShares327.06K
TypeSH
Market value$5.74M
0.43%
Sole
0.00
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
DFNDShares263.25K
TypeSH
Market value$5.71M
0.43%
Sole
0.00
Shared
0.00
None
0.00
IMAGENEBIO INC
DFNDShares823.78K
TypeSH
Market value$5.68M
0.43%
Sole
0.00
Shared
0.00
None
0.00
IMMIX BIOPHARMA INC
DFNDShares986.24K
TypeSH
Market value$5.16M
0.39%
Sole
0.00
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares212.64K
TypeSH
Market value$4.89M
0.37%
Sole
0.00
Shared
0.00
None
0.00
IMMUNEERING CORP
DFNDShares665K
TypeSH
Market value$4.38M
0.33%
Sole
0.00
Shared
0.00
None
0.00
PALVELLA THERAPEUTICS INC NE
DFNDShares40.26K
TypeSH
Market value$4.21M
0.32%
Sole
0.00
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
DFNDShares515K
TypeSH
Market value$4.21M
0.32%
Sole
0.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
BLACKROCK INC COMDFND | COM | 945.95K | SH | $1.01B 75.76% | 0.00 | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 3.36M | SH | $30.35M 2.27% | 0.00 | 0.00 | 0.00 |
NUVEEN CHURCHILL DIRECT LENDDFND | COM SHS | 2.14M | SH | $28.60M 2.14% | 0.00 | 0.00 | 0.00 |
BLUE OWL CAPITAL CORPORATIONDFND | COM | 2.05M | SH | $26.12M 1.95% | 0.00 | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 6.82M | SH | $26.00M 1.95% | 0.00 | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCDFND | COM | 2.35M | SH | $24.33M 1.82% | 0.00 | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCDFND | COM | 3.47M | SH | $18.62M 1.39% | 0.00 | 0.00 | 0.00 |
HOLLEY INCDFND | COM | 4.15M | SH | $17.13M 1.28% | 0.00 | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCDFND | COM | 7.43M | SH | $10.93M 0.82% | 0.00 | 0.00 | 0.00 |
CONDUENT INCDFND | COM | 4.82M | SH | $9.26M 0.69% | 0.00 | 0.00 | 0.00 |
REPARE THERAPEUTICS INCDFND | COM | 3.44M | SH | $8.95M 0.67% | 0.00 | 0.00 | 0.00 |
CIVEO CORPDFND | CDA COM NEW | 370.53K | SH | $8.47M 0.63% | 0.00 | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 1.24M | SH | $7.36M 0.55% | 0.00 | 0.00 | 0.00 |
EYEPOINT INCDFND | COM NEW | 392.59K | SH | $7.17M 0.54% | 0.00 | 0.00 | 0.00 |
PROCORE TECHNOLOGIES INCDFND | COM | 94.26K | SH | $6.86M 0.51% | 0.00 | 0.00 | 0.00 |
DELL TECHNOLOGIES INCDFND | CL C | 53.85K | SH | $6.78M 0.51% | 0.00 | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCDFND | COM | 360K | SH | $5.81M 0.44% | 0.00 | 0.00 | 0.00 |
MAPLIGHT THERAPEUTICS INCDFND | COM | 327.06K | SH | $5.74M 0.43% | 0.00 | 0.00 | 0.00 |
ROIVANT SCIENCES LTDDFND | SHS | 263.25K | SH | $5.71M 0.43% | 0.00 | 0.00 | 0.00 |
IMAGENEBIO INCDFND | COM | 823.78K | SH | $5.68M 0.43% | 0.00 | 0.00 | 0.00 |
IMMIX BIOPHARMA INCDFND | COM | 986.24K | SH | $5.16M 0.39% | 0.00 | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 212.64K | SH | $4.89M 0.37% | 0.00 | 0.00 | 0.00 |
IMMUNEERING CORPDFND | CLASS A COM | 665K | SH | $4.38M 0.33% | 0.00 | 0.00 | 0.00 |
PALVELLA THERAPEUTICS INC NEDFND | COM | 40.26K | SH | $4.21M 0.32% | 0.00 | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCDFND | COM | 515K | SH | $4.21M 0.32% | 0.00 | 0.00 | 0.00 |
Page 1 of 4